Altamira Therapeutics Stock Price on April 10, 2024
| CYTO Stock | USD 0.08 0.06 41.36% |
Below is the normalized historical share price chart for Altamira Therapeutics extending back to August 06, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Altamira Therapeutics stands at 0.08, as last reported on the 26th of December, with the highest price reaching 0.20 and the lowest price hitting 0.08 during the day.
If you're considering investing in Altamira Stock, it is important to understand the factors that can impact its price. Altamira Therapeutics secures Sharpe Ratio (or Efficiency) of -0.26, which signifies that the company had a -0.26% return per unit of risk over the last 3 months. Altamira Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Altamira Therapeutics' Mean Deviation of 4.99, risk adjusted performance of (0.17), and Standard Deviation of 9.2 to double-check the risk estimate we provide.
At this time, Altamira Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 26th of December 2024, Common Stock Shares Outstanding is likely to grow to about 515.8 K, while Common Stock Total Equity is likely to drop about 97.6 K. . At this time, Altamira Therapeutics' Price To Sales Ratio is very stable compared to the past year. As of the 26th of December 2024, Price Book Value Ratio is likely to grow to 0.23, while Price Earnings Ratio is likely to drop (0.21). Altamira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of August 2014 | 200 Day MA 1.0789 | 50 Day MA 0.4647 | Beta 2.442 |
Altamira |
Sharpe Ratio = -0.2553
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYTO |
Estimated Market Risk
| 10.14 actual daily | 90 90% of assets are less volatile |
Expected Return
| -2.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Altamira Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Altamira Therapeutics by adding Altamira Therapeutics to a well-diversified portfolio.
Price Book 0.0491 | Enterprise Value Ebitda (0.47) | Price Sales 0.6382 | Shares Float 2.7 M | Wall Street Target Price 5.0063 |
Altamira Therapeutics Main Headline on 10th of April 2024
Altamira Therapeutics Provides Business Update, Reports Full... by finance.yahoo.com
Hamilton, Bermuda, April 10, 2024 -- Management to host conference call today, April 10, at 8.30 a.m. EDTRNA delivery business progressing with new collaborations, potential new applicationsPartnering of legacy assets underway as Company transitions to focused RNA delivery technology providerAchieved 85 percent reduction in net loss to CHF 3.9 million and eliminated financial debtFinished year with shareholders equity of CHF 6.5 million, improved by CHF 14.8 million HAMILTON, BERMUDA
Altamira Therapeutics Valuation on April 10, 2024
It is possible to determine the worth of Altamira Therapeutics on a given historical date. On April 10, 2024 Altamira was worth 1.87 at the beginning of the trading date compared to the closed value of 2.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Altamira Therapeutics stock. Still, in general, we apply an absolute valuation method to find Altamira Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Altamira Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Altamira Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.92 | 2.03 | 1.86 | 1.86 | 121,135 | |
04/10/2024 | 1.87 | 2.01 | 1.87 | 2.00 | 176,244 |
| 1.94 | 1.99 | 1.80 | 1.82 | 171,833 |
| Backtest Altamira Therapeutics | | | Altamira Therapeutics History | | | Altamira Therapeutics Valuation | Previous | Next |
Altamira Therapeutics Trading Date Momentum on April 10, 2024
| On April 11 2024 Altamira Therapeutics was traded for 1.82 at the closing time. The top price for the day was 1.99 and the lowest listed price was 1.80 . The trading volume for the day was 171.8 K. The trading history from April 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 9.00% . The overall trading delta against the current closing price is 30.50% . |
Altamira Therapeutics Fundamentals Correlations and Trends
By evaluating Altamira Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Altamira Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Altamira financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Altamira Therapeutics Stock history
Altamira Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Altamira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Altamira Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Altamira Therapeutics stock prices may prove useful in developing a viable investing in Altamira Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 491.3 K | 515.8 K | |
| Net Loss | -20 M | -21 M |
Altamira Therapeutics Stock Technical Analysis
Altamira Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Altamira Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Altamira Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Altamira Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Altamira Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Altamira Therapeutics shares will generate the highest return on investment. By undertsting and applying Altamira Therapeutics stock market strength indicators, traders can identify Altamira Therapeutics entry and exit signals to maximize returns
Altamira Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Altamira Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Altamira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Altamira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (2.10) | |||
| Total Risk Alpha | (2.53) | |||
| Treynor Ratio | 2.45 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altamira Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Altamira Stock, please use our How to Invest in Altamira Therapeutics guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altamira Therapeutics. If investors know Altamira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altamira Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.82 | Revenue Per Share 0.917 | Quarterly Revenue Growth (0.64) | Return On Assets (0.57) | Return On Equity (3.69) |
The market value of Altamira Therapeutics is measured differently than its book value, which is the value of Altamira that is recorded on the company's balance sheet. Investors also form their own opinion of Altamira Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Altamira Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altamira Therapeutics' market value can be influenced by many factors that don't directly affect Altamira Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altamira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Altamira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altamira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.